Researchers from the Medical University of South Carolina (MUSC) Hollings Cancer Center in Charleston have received a three-year, $1.2 million grant from the U.S. Department of Defense to use molecular imaging tools to test antibody therapies for breast cancer—potentially producing fewer side effects.

NorthStar Medical Radioisotopes in Beloit, Wis. and the Janesville, Wis.-planned SHINE Medical Technologies may receive a portion of the $20 million in federal technology funding bill approved by President Donald Trump to produce molybdenum-99 (Mo-99).

Diffusion-weighted imaging (DWI) could help differentiate between benign and malignant tumors and predict tumor recurrence in breast cancer patients, according to research published Oct. 4 in Academic Radiology. The authors noted that DWI may also serve as a beneficial supplement to contrast-enhanced breast MRI.

A new hybrid nanoplatform that simultaneously uses three types of imaging modalities—MRI, CT and fluorescence optical imaging—to locate tumors could give a new edge to molecular imaging and tumor diagnosis.  

Liana Apostolova, MD, a researcher at the Indiana University School of Medicine, has won a five-year, $44.7 million research grant from the National Institutes of Health (NIH) to study early-onset Alzheimer's disease with MRI and PET imaging, according to an Oct. 4 report by the Indianapolis Business Journal.

A novel brain MRI based method can track myelin—responsible for insulating nerve fibers—and may enable clinicians to identify myelin content changes in MS patients and patients whose myelin has been damaged by stroke or traumatic brain injury.

International researchers from the Child Mind Institute in New York have released non-human primate brain imaging data sets aimed to develop wiring diagrams and improve the understanding of brain disorders in humans.  

Annual lung screenings of older-aged current and former smokers should be conducted more regularly, potentially saving up to 65,000 lives in the U.S. each year, according to findings from the NELSON study presented at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer in Toronto, Ontario, Canada.